| 000 | 01850 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517025433.0 | ||
| 264 | 0 | _c20160111 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0123670 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGervasoni, Cristina | |
| 245 | 0 | 0 |
_aMetabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages? _h[electronic resource] |
| 260 |
_bPloS one _c2015 |
||
| 300 |
_ae0123670 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 |
_aAtazanavir Sulfate _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 |
_aDyslipidemias _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperbilirubinemia _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrolithiasis _xblood |
| 650 | 0 | 4 |
_aRitonavir _xadverse effects |
| 650 | 0 | 4 |
_aViral Load _xdrug effects |
| 700 | 1 | _aMeraviglia, Paola | |
| 700 | 1 | _aMinisci, Davide | |
| 700 | 1 | _aFerraris, Laurenzia | |
| 700 | 1 | _aRiva, Agostino | |
| 700 | 1 | _aLandonio, Simona | |
| 700 | 1 | _aCozzi, Valeria | |
| 700 | 1 | _aCharbe, Nitin | |
| 700 | 1 | _aMolinari, Lara | |
| 700 | 1 | _aRizzardini, Giuliano | |
| 700 | 1 | _aClementi, Emilio | |
| 700 | 1 | _aGalli, Massimo | |
| 700 | 1 | _aCattaneo, Dario | |
| 773 | 0 |
_tPloS one _gvol. 10 _gno. 4 _gp. e0123670 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0123670 _zAvailable from publisher's website |
| 999 |
_c24805827 _d24805827 |
||